Sign Up

Get a digest of top content straight to your inbox


Analytics, Software Services, Consulting

Lorus Therapeutics Announces Positive Result in its Phase II Clinical Study of LOR-2040 in Acute Myeloid Leukemia (AML)

Efficacy and safety data supports advancement to a comparative trial as a strategy to support registration…Read more pdf